Nevro Corp.
NVRO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.06 | 0.00 | -4.56 | -0.41 |
| FCF Yield | -21.18% | -8.71% | 1.23% | -1.92% |
| EV / EBITDA | -2.33 | -11.39 | 70.18 | -28.86 |
| Quality | ||||
| ROIC | -26.07% | -16.77% | -13.16% | -18.37% |
| Gross Margin | 65.98% | 68.22% | 68.01% | 68.76% |
| Cash Conversion Ratio | 0.17 | 0.64 | 8.22 | 0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.18% | 3.19% | 3.92% | -0.29% |
| Free Cash Flow Growth | 56.65% | -493.53% | 131.60% | -1,021.66% |
| Safety | ||||
| Net Debt / EBITDA | -1.24 | -1.50 | 3.65 | -1.29 |
| Interest Coverage | -4.69 | -12.39 | -15.37 | -4.60 |
| Efficiency | ||||
| Inventory Turnover | 1.35 | 1.14 | 1.30 | 1.29 |
| Cash Conversion Cycle | 271.19 | 327.90 | 275.27 | 252.27 |